Filter posts

BIO Investor Forum: The New Kids on the Biotech Block

Where should biotech start-ups look for funding in the venture capital desert that is becoming …

34 daily newspapers from California urge voters to vote NO on Prop 37

In recent editorials, California’s major daily newspapers are urging voters to reject Proposition 37 on …

BIO Technology Transfer Symposium: Funding that First $2 Million

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, …

Cancer Stem Cell Therapy: Real Or Just Hype?

Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem …

Take the Pledge, Support FuelsAmerica

Fuels America is a new coalition of groups and individuals who have a stake in …

How does the NBI perform in the last quarter of the year?

Does the NASDAQ Biotech Index (NBI) outperform the broader market in the last three months …

What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?

The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more …

#BIF2012 Company Snapshot: Chimerix

Our next Company Snapshot for next week’s BIO Investor Forum is Chimerix. They will be …

Is the early-stage IPO making a comeback?

Yesterday was the NASDAQ debut for preclinical-stage biotech Regulus (RGLS). The microRNA platform company is …

“Approval of Foods from Genetically Modified Animals is Unjustifiably Slow”

The Los Angeles Times reported on concerns within the U.S. animal biotech industry and the …